POET Technologies (NasdaqCM:POET) is back in focus after signing a multi-year supply and joint development agreement with Lumilens, tied to potential orders above US$500 million and a separate US$400 million direct equity offering.

POET’s share price has swung sharply, with a 1-day share price return down 22.36% after a strong run that saw the 30-day share price return reach 119.97% and the 1-year total shareholder return hit 239.07%, as investors reacted to the Lumilens agreement, new collaborations, the US$400 million direct offering, earnings and short-seller scrutiny.

If the AI optics story has your attention, this is also a good moment to see what else is moving in related areas of the market through 42 AI infrastructure stocks

After a rally that pushed POET’s 1 year return above 200%, shares now trade well above the US$8.20 analyst price target and sit on a value score of 1. This raises the question: is there still a buying opportunity here, or is the market already pricing in years of future growth?

Most Popular Narrative: 8.1% Undervalued

POET’s most followed narrative pegs fair value at $17.37, a little above the last close at $15.97, which puts the recent surge in a different light.

POET Technologies is not just a component manufacturer, it is the architect of the "optical nervous system" for the AI era. While the market focuses on GPUs (Nvidia), the critical bottleneck has shifted to data transfer speeds and energy efficiency. POET's "Optical Interposer" platform solves both. With confirmed partnerships (Foxconn, Mitsubishi, Celestial AI) and a massive $250 million capital injection, the company has de risked its financial profile and is entering a hyper growth phase.

Curious what justifies a fair value above today’s price after such a huge run. The narrative leans heavily on aggressive revenue expansion, rising margins and a premium future earnings multiple. The real surprise is how these three levers are combined to back into that target.

Result: Fair Value of $17.37 (UNDERVALUED)

However, this depends on POET turning US$1.41 million of revenue and a US$81.65 million net loss into meaningful earnings while managing execution and partner dependency risks.

Next Steps

With sentiment clearly split between risk and reward, this is the moment to move quickly and weigh the full picture for yourself with 1 key reward and 4 important warning signs

Looking for more investment ideas?

Do not leave your research at a single stock. Broaden your watchlist with a few focused ideas that could sharpen how you think about risk and return.

• Spot potential high-return outliers early by scanning a hand picked pool of smaller companies through 27 elite penny stocks with strong financials.
• Hunt for quality at a reasonable price by checking companies that combine fundamentals with attractive pricing using the 51 high quality undervalued stocks.
• Strengthen the defensive side of your portfolio by reviewing companies screened for financial resilience and consistent metrics with the 65 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.